Evaluation and Management of Memory Changes
When a patient presents with memory changes, obtain a detailed history from both the patient AND a reliable informant (family member or care partner) focusing on four key domains: cognition, activities of daily living, mood/neuropsychiatric symptoms, and sensorimotor function, followed by office-based cognitive testing to determine if a neurocognitive disorder exists. 1
Initial Evaluation Framework
History Taking - The Four Critical Domains
The cornerstone of evaluation is obtaining reliable collateral information from an informant, as patients often cannot accurately report their own cognitive decline 1:
- Cognitive changes: Document the specific nature, onset pattern (insidious vs. acute), tempo of progression, and which cognitive domains are affected (memory, language, executive function, visuospatial abilities) 1
- Functional impact: Assess both basic ADLs (bathing, dressing, eating) and instrumental ADLs (managing finances, medications, driving, cooking) to determine severity 1
- Neuropsychiatric symptoms: Screen for depression, anxiety, apathy, agitation, hallucinations, delusions, and personality changes 1
- Sensorimotor function: Evaluate for motor symptoms (tremor, rigidity, gait changes) and sensory deficits that may suggest specific etiologies 1
Risk Factor Assessment
Systematically evaluate individualized risk factors for cognitive decline 1:
- Modifiable factors: Vascular risk factors (hypertension, diabetes, hyperlipidemia), obstructive sleep apnea, medications that impair cognition, alcohol use, depression, hearing/vision loss 1
- Non-modifiable factors: Age, family history, genetic factors, educational/occupational attainment 1
- Comorbid conditions: Multiple pathologies commonly coexist in older adults, but identify the primary driver of symptoms 1
Office-Based Cognitive Testing
Perform validated cognitive screening tests covering multiple domains 1:
- Memory: Delayed recall and recognition testing
- Attention/Executive function: Serial 7s, digit span, trail making
- Language: Naming, fluency, comprehension
- Visuospatial: Clock drawing, figure copying
Red Flags Requiring Urgent Evaluation or Specialist Referral
Immediately escalate or refer patients with these features 1:
- Rapidly progressive dementia: Cognitive decline developing over weeks to months rather than years
- Early-onset dementia: Age < 65 years at symptom onset
- Atypical presentations: Prominent language abnormalities, behavioral changes, or sensorimotor dysfunction of cerebral origin
- Delirium features: Acute confusion with attentional impairment requiring urgent/emergent evaluation
- Uncertain interpretation: When office testing is inconclusive or confounded by educational level, language barriers, or complex medical profiles
When to Order Neuropsychological Testing
Formal neuropsychological evaluation is indicated when 1:
- Patient or caregiver report concerning symptoms in daily life BUT office cognitive testing is normal
- Office examination shows abnormalities BUT interpretation is uncertain due to complex clinical profile or demographic confounders (very high or low education)
- Need to detect very mild cognitive impairment that brief office tests may miss
Diagnostic Formulation
The evaluation aims to establish three components 1:
- Cognitive status: Normal, mild cognitive impairment (MCI), or dementia
- Syndromic diagnosis: Amnestic vs. non-amnestic presentation (language, visuospatial, executive dysfunction variants)
- Etiologic diagnosis: Most likely underlying cause (Alzheimer's disease, vascular, Lewy body, frontotemporal, etc.)
Alzheimer's Disease Diagnostic Criteria
Probable AD dementia requires 1:
- Meets criteria for dementia (cognitive decline from baseline affecting daily function)
- Insidious onset over months to years (not sudden)
- Clear-cut history of worsening cognition
- Initial deficits in one of these patterns:
- Amnestic (most common): Impaired learning and recall of recent information plus deficits in ≥1 other domain
- Language: Word-finding difficulty predominates
- Visuospatial: Spatial cognition, object recognition, face recognition deficits
- Executive: Impaired reasoning, judgment, problem-solving
Exclude AD diagnosis if 1:
- Substantial cerebrovascular disease temporally related to cognitive decline
- Core features of Lewy body dementia (visual hallucinations, parkinsonism, REM sleep behavior disorder)
- Prominent behavioral variant frontotemporal dementia features
- Prominent semantic or non-fluent primary progressive aphasia features
Management Approach
Non-Pharmacological Strategies (First-Line)
Primary care physicians most frequently recommend 2:
- Physical activity: Regular aerobic exercise
- Cognitive stimulation: Mentally engaging activities
- Dietary modifications: Mediterranean or MIND diet patterns
- Social engagement: Maintaining social connections and activities
Pharmacological Considerations
- Vascular risk factor management: Most frequently prescribed when medications are used, targeting hypertension, diabetes, hyperlipidemia to reduce further cognitive decline 2
- Avoid cognitive-impairing medications: Review and discontinue anticholinergics, benzodiazepines, and other potentially harmful drugs 1
- Disease-modifying therapies: Consider for appropriate candidates with confirmed AD pathology (requires specialist consultation and biomarker confirmation)
Common Pitfalls to Avoid
- Underdiagnosis due to therapeutic nihilism: Current guidelines emphasize diagnosis is important even when disease-modifying treatments are limited, as it enables planning, safety measures, and access to supportive services 3
- Relying solely on patient report: Patients often lack insight into their deficits; collateral information from informants is essential 1
- Missing treatable causes: Depression, medication effects, metabolic disorders, vitamin deficiencies, and sleep apnea can cause or worsen cognitive symptoms 4
- Delaying specialist referral: Atypical, early-onset, or rapidly progressive cases require expedited specialist evaluation 1